1. ZHAW digitalcollection
  2. Life Sciences und Facility Management
  3. Publikationen
  4. Publikationen Life Sciences und Facility Management
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWuillemin, Michel A.-
dc.contributor.authorStuber, Wanda T.-
dc.contributor.authorFox, Thomas-
dc.contributor.authorReber, Michael J.-
dc.contributor.authorBrühwiler, Dominik-
dc.contributor.authorAlberto, Roger-
dc.contributor.authorBraband, Henrik-
dc.date.accessioned2018-02-05T10:42:48Z-
dc.date.available2018-02-05T10:42:48Z-
dc.date.issued2014-
dc.identifier.issn1477-9226de_CH
dc.identifier.issn1477-9235de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/2607-
dc.description.abstractThe reaction of high-valent fac-{99mTcO3}+ complexes with alkenes ((3+2)-cycloaddition) has been used to develop a novel labelling procedure for silica based particles. This strategy can help to gain more detailed in vivo data of mesoporous silica by non-invasive radioimaging in the future. By applying norbornene as a coupling unit the (3+2)-cycloaddition reaction proceeds stereoselectively and with high reaction rates.de_CH
dc.language.isoende_CH
dc.publisherRoyal Society of Chemistryde_CH
dc.relation.ispartofDalton Transactionsde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subjectTechnetiumde_CH
dc.subjectMesoporousde_CH
dc.subjectRadioimagingde_CH
dc.subjectSilicade_CH
dc.subject.ddc540: Chemiede_CH
dc.subject.ddc610: Medizin und Gesundheitde_CH
dc.titleA novel 99mTc labelling strategy for the development of silica based particles for medical applicationsde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
dc.identifier.doi10.1039/C3DT53019Ade_CH
zhaw.funding.euNode_CH
zhaw.issue11de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.end4263de_CH
zhaw.pages.start4260de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume43de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeedPolymerchemiede_CH
zhaw.funding.zhawMolecular Alignment Chips (MACs)de_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
There are no files associated with this item.
Show simple item record
Wuillemin, M. A., Stuber, W. T., Fox, T., Reber, M. J., Brühwiler, D., Alberto, R., & Braband, H. (2014). A novel 99mTc labelling strategy for the development of silica based particles for medical applications. Dalton Transactions, 43(11), 4260–4263. https://doi.org/10.1039/C3DT53019A
Wuillemin, M.A. et al. (2014) ‘A novel 99mTc labelling strategy for the development of silica based particles for medical applications’, Dalton Transactions, 43(11), pp. 4260–4263. Available at: https://doi.org/10.1039/C3DT53019A.
M. A. Wuillemin et al., “A novel 99mTc labelling strategy for the development of silica based particles for medical applications,” Dalton Transactions, vol. 43, no. 11, pp. 4260–4263, 2014, doi: 10.1039/C3DT53019A.
WUILLEMIN, Michel A., Wanda T. STUBER, Thomas FOX, Michael J. REBER, Dominik BRÜHWILER, Roger ALBERTO und Henrik BRABAND, 2014. A novel 99mTc labelling strategy for the development of silica based particles for medical applications. Dalton Transactions. 2014. Bd. 43, Nr. 11, S. 4260–4263. DOI 10.1039/C3DT53019A
Wuillemin, Michel A., Wanda T. Stuber, Thomas Fox, Michael J. Reber, Dominik Brühwiler, Roger Alberto, and Henrik Braband. 2014. “A Novel 99mTc Labelling Strategy for the Development of Silica Based Particles for Medical Applications.” Dalton Transactions 43 (11): 4260–63. https://doi.org/10.1039/C3DT53019A.
Wuillemin, Michel A., et al. “A Novel 99mTc Labelling Strategy for the Development of Silica Based Particles for Medical Applications.” Dalton Transactions, vol. 43, no. 11, 2014, pp. 4260–63, https://doi.org/10.1039/C3DT53019A.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.